Article
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and…
medRxiv · 2025 · Mao, Z.; Hirdler, J. B.; Gicobi, J. K.; Maynes, M.; Hsu, M. A.; Dellacecca, E. R.; Zhang, W.; Teske, J. J.; Li, Y.; Zhao, G.; Lucien-matteoni, F.; Borges da Silva, H.; Billadeau, D. D.; Dong, H.
Key facts
| Title | PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunity |
|---|---|
| First author | Mao, Z.; Hirdler, J. B.; Gicobi, J. K.; Maynes, M.; Hsu, M. A.; Dellacecca, E. R.; Zhang, W.; Teske, J. J.; Li, Y.; Zhao, G.; Lucien-matteoni, F.; Borges da Silva, H.; Billadeau, D. D.; Dong, H. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.18.631253 |
| Devices mentioned | K802418 |
| Product codes mentioned | KIS, LXG, MVU, PFF, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1